0001705110-26-000011
SEC filingAngi Inc. reported revenue of $1.03 billion for fiscal year 2025, generating a gross profit of $983.1 million. The company achieved operating income of $65.4 million and net earnings attributable to shareholders of $43.8 million, with both basic and diluted earnings per share at $1.00. Key financial drivers included strong gross margins offset by significant selling and marketing expenses of $507.5 million. The company generated $105.1 million in operating cash flow but had a net cash decrease of $112.8 million due to $59.5 million in investing activities and $158.3 million in financing activities, primarily from treasury stock purchases. The balance sheet shows total assets of $1.68 billion with shareholders' equity of $927.4 million and long-term debt of $497.7 million.
Angi Inc. reported fiscal year 2025 results with revenue of $1.03 billion and net earnings attributable to shareholders of $43.8 million. The company achieved operating income of $65.4 million, representing a 6.3% operating margin. Gross profit was $983.1 million, reflecting a 95.4% gross margin. Both basic and diluted earnings per share were $1.00. The company generated $105.1 million in operating cash flow but experienced a net cash decrease of $112.8 million due to significant investing and financing activities.
No segment breakdown, geographic mix, or specific growth drivers were disclosed in the provided financial data. The company reported total revenue of $1.03 billion with cost of revenue of $47.4 million, resulting in a gross profit of $983.1 million. The document does not provide information about revenue composition by business segment, product line, or geographic region.
The company maintained strong gross margins of 95.4% for fiscal year 2025. Operating margin was 6.3% with operating income of $65.4 million. The cost structure included selling and marketing expenses of $507.5 million (49.3% of revenue), general and administrative expenses of $262.9 million (25.5% of revenue), and product development expenses of $87.4 million (8.5% of revenue). Other significant costs included depreciation of $45.3 million, restructuring charges of $12.8 million, and amortization of intangibles of $1.8 million.
Operating cash flow was $105.1 million, derived from net earnings of $43.8 million plus adjustments including depreciation of $45.3 million and provision for credit losses of $48.5 million. Investing activities used $59.5 million, primarily for capital expenditures of $59.6 million. Financing activities used $158.3 million, mainly from purchases of treasury stock of $148.7 million. The balance sheet shows total assets of $1.68 billion including cash and equivalents of $303.7 million, goodwill of $890.1 million, and intangible assets of $167.1 million. Total liabilities were $752.6 million including long-term debt of $497.7 million, with shareholders' equity of $927.4 million.
No management guidance, strategic priorities, or specific risk factors were disclosed in the provided financial data. The document contains only financial statement information without forward-looking statements, management discussion and analysis, or outlook commentary.